In vitro Synergism of Six Antituberculosis Agents Against Drug-Resistant Mycobacterium tuberculosis Isolated from Retreatment Tuberculosis Patients

BACKGROUND: Retreatment tuberculosis (TB) has become a major source of drug-resistant TB. In contrast to the combination of isoniazid (INH) and rifampicin (RIF), that of pasiniazid (Pa) and rifabutin (RFB) or rifapentine (RFP) appears to have better activity in vitro against drug-resistant Mycobacte...

Descripción completa

Detalles Bibliográficos
Autores principales: Ying, Ruoyan, Huang, Xiaochen, Gao, Yaxian, Wang, Jie, Liu, Yidian, Sha, Wei, Yang, Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8449861/
https://www.ncbi.nlm.nih.gov/pubmed/34548797
http://dx.doi.org/10.2147/IDR.S322563

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8449861/
https://www.ncbi.nlm.nih.gov/pubmed/34548797
http://dx.doi.org/10.2147/IDR.S322563

Ejemplares similares